Literature DB >> 2974419

The in vitro stability of doxifluridine in whole blood and plasma.

L J Schaaf1, B R Dobbs, I R Edwards, D G Perrier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2974419     DOI： 10.1007/bf01046718

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  4 in total

1.  Analysis of 5'-deoxy-5-fluorouridine and 5-fluorouracil in human plasma and urine by high-performance liquid chromatography.

Authors:  L J Schaaf; D G Ferry; C T Hung; D G Perrier; I R Edwards
Journal:  J Chromatogr       Date:  1985-08-09

2.  Pharmacology of 5'-deoxy-5-fluorouridine in patients with resistant ovarian cancer.

Authors:  E A de Bruijn; A T van Oosterom; U R Tjaden; H J Reeuwijk; H M Pinedo
Journal:  Cancer Res       Date:  1985-11       Impact factor: 12.701

3.  Nonlinear pharmacokinetic characteristics of 5-fluorouracil (5-FU) in colorectal cancer patients.

Authors:  L J Schaaf; B R Dobbs; I R Edwards; D G Perrier
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

4.  The pharmacokinetics of doxifluridine and 5-fluorouracil after single intravenous infusions of doxifluridine to patients with colorectal cancer.

Authors:  L J Schaaf; B R Dobbs; I R Edwards; D G Perrier
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953
  4 in total
  2 in total

1.  Pharmacokinetics and bioavailability of oral 5'-deoxy-5-fluorouridine in cancer patients.

Authors:  S A Van Der Heyden; M S Highley; E A De Bruijn; U R Tjaden; H J Reeuwijk; H Van Slooten; A T Van Oosterom; R A Maes
Journal:  Br J Clin Pharmacol       Date:  1999-04       Impact factor: 4.335

2.  Pharmacokinetic study of doxifluridine given by 5-day stepped-dose infusion.

Authors:  P A Reece; I N Olver; R G Morris; J F Bishop; T W Guentert; H S Hill; B L Hillcoat
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.